{
    "brief_title": "Regimens Comparison for Breast Cancers of Positive Lymph Nodes",
    "phase": "Phase 3",
    "drugs": "['Epirubicin, CTX, Paclitaxel', 'Epirubicin, Paclitaxel']",
    "drugs_list": [
        "Epirubicin",
        "CTX",
        "Paclitaxel",
        "Epirubicin",
        "Paclitaxel"
    ],
    "diseases": "['Breast Cancer']",
    "diseases_list": [
        "Breast Cancer"
    ],
    "enrollment": "1000.0",
    "inclusion_criteria": "inclusion criteria: \n\n patients with breast cancer after breast cancer surgery with positive lymph nodes age 18-70 years old \n\n ",
    "exclusion_criteria": ": \n\n with other malignance disease",
    "brief_summary": "To compare the efficacy and safety of EC-T and ET regimen as adjuvant treatment of breast cancer patients with positive lymph nodes",
    "NCT_ID": "NCT01134523"
}